News

Zacks Investment Research on MSN7h
Recursion Pharmaceuticals (RXRX) Rises Higher Than Market: Key Facts
In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $5.52, marking a +2.41% move from the previous day. The stock outperformed the S&P 500, which registered a daily gain of 0.54% ...
Gain-of-function research is more than just tweaking risky viruses – it’s a routine and essential tool in all biology research
Gain-of-function experiments are ingrained in the scientific process. In many instances, the benefits that stem from gain-of-function experiments are not immediately clear. Only decades later does the ...
Zacks Investment Research on MSN13h
Recursion Pharmaceuticals Rises 6% in a Month: How to Play the Stock
Recursion Pharmaceuticals RXRX shares have gained 5.5% in a month. The stock gained momentum after the company announced the ...